Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments on human cell lines for the bioartificial liver.

R Hoekstra1, R A F M Chamuleau

  • 1Department of Experimental Hepatology, Academic Medical Center, University of Amsterdam, The Netherlands. r.hoekstra@amc.uva.nl

The International Journal of Artificial Organs
|May 10, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Feasibility and acceptability of a mixed methods within-subjects comparative design in dance movement therapy for adults with personality disorders.

Pilot and feasibility studies·2026
Same author

Power-Law Scaling Relating the Average Charge State and Kinetic Energy in Expanding Laser-Driven Plasmas.

Physical review letters·2024
Same author

Team dynamics and clinician's experience influence decision-making during Upper-GI multidisciplinary team meetings: A multiple case study.

Frontiers in oncology·2022
Same author

Cross-calibration of a combined electrostatic and time-of-flight analyzer for energy- and charge-state-resolved spectrometry of tin laser-produced plasma.

Applied physics. B, Lasers and optics·2022
Same author

The Impact of Tumor Regression on Prognosis After Neoadjuvant Chemoradiotherapy in Surgically Treated Esophageal Adenocarcinoma.

Annals of surgical oncology·2022
Same author

ASO Author Reflections: Improvement of Esophageal Cancer Staging by Implementing Mandard Tumor Regression Score.

Annals of surgical oncology·2022
Same journal

Therapeutic plasma exchange added to CRRT combined with hemoperfusion in wasp sting-associated AKI: A multicenter retrospective cohort study.

The International journal of artificial organs·2026
Same journal

Development of an early prediction model for ICU-acquired weakness in sepsis using PNI and SII.

The International journal of artificial organs·2026
Same journal

Foot care behaviors and perceived exercise benefits and barriers in diabetic hemodialysis patients.

The International journal of artificial organs·2026
Same journal

First clinical experience with citrate-anticoagulated CVVHD-based low-flow ECCO<sub>2</sub>R in severe hypercapnic respiratory failure.

The International journal of artificial organs·2026
Same journal

Carboxyhemoglobin levels for the detection of hemolysis in patients supported by left ventricular assist devices: A case series.

The International journal of artificial organs·2026
Same journal

Evaluation of arteriovenous fistulas of obtuse anastomosis in reducing thrombosis using computational fluid dynamics.

The International journal of artificial organs·2026
See all related articles

Alternatives to porcine cells in bioartificial liver (BAL) devices are explored. Human liver cell lines and stem cells show promise but require further development for safe and effective use in liver support.

Area of Science:

  • Hepatology
  • Regenerative Medicine
  • Biomaterials

Background:

  • Bioartificial liver (BAL) devices traditionally use porcine hepatocytes, posing xenotransplantation risks.
  • Human liver cell lines (HepG2, C3A) offer growth advantages but have insufficient detoxification and ureagenesis functions.
  • Need for safer, more functional alternatives to porcine cells in BAL devices.

Purpose of the Study:

  • To evaluate human liver cell lines and stem cells as alternatives for BAL devices.
  • To assess the potential of immortalized human hepatocytes and differentiated stem cells.
  • To identify challenges in developing safe and functional cellular components for BAL.

Main Methods:

  • Review of human liver cell lines (HepG2, C3A) and their functions.

Related Experiment Videos

  • Exploration of immortalization strategies for human hepatocytes (conditional immortalization, telomerase).
  • Investigation of human embryonic and adult stem cell differentiation into hepatic lineages.

    • Main Results:

    • Tumor-derived human liver cell lines exhibit limited ammonia detoxification and ureagenesis.
    • Conditional immortalization and telomerase offer potential control over hepatocyte transformation.
    • In vitro hepatic differentiation of rodent stem cells suggests applicability to human stem cells.

    Conclusions:

    • Immortalized human liver cell lines and differentiated stem cells are promising for BAL devices.
    • Further improvements in functionality and safety are crucial for clinical application.
    • Human cell-based BAL devices require continued research and development.